Tatyana Belimova
Nurse Practitioner · Harrisburg, PANPI 1114493186
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 457 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Amgen at 34.4% of the total. Reporting peaked in 2021 at $2,806 and has fallen 80.8% since, to $537 in 2025. Among nurse practitioner clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 457 payments — averaging $22.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$1K
- Johnson & Johnson$1K
- UCB, Inc.$807
- AstraZeneca$767
- GSK$566
- plus $2K from 24 others
What the payments were for
- Food & beverage$10,27198%
- Education$1992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 139 | $3,604 |
| AbbVie | 64 | $1,446 |
| Johnson & Johnson(2 entities) | 41 | $1,170 |
| UCB, Inc. | 43 | $807 |
| AstraZeneca(2 entities) | 39 | $767 |
| GSK | 22 | $566 |
| Pfizer | 23 | $468 |
| Lilly USA, LLC | 17 | $296 |
| Novartis | 13 | $221 |
| Fresenius Kabi USA, LLC | 8 | $175 |
| E.r. Squibb & Sons, L.L.C. | 7 | $142 |
| Cumberland Pharmaceuticals, Inc. | 5 | $134 |
| Sanofi | 5 | $106 |
| Aurinia Pharma U.S., Inc. | 4 | $67 |
| Radius Health, Inc. | 3 | $55 |
| ANI Pharmaceuticals, Inc. | 3 | $54 |
| Genentech USA, Inc. | 3 | $50 |
| Ferring Pharmaceuticals Inc. | 2 | $43 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| Sandoz | 2 | $32 |
| CSL Behring | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 2 | $24 |
| Heartflow, Inc. | 1 | $22 |
| Argenx US, Inc. | 1 | $21 |
| Neurelis, Inc. | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Sobi, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,470 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $114,071 |
| EnbrelEtanercept | 11 | $79,803 |
| Orencia ClickjectAbatacept | 12 | $61,774 |
| OtezlaApremilast | 12 | $56,269 |
| MethotrexateMethotrexate Sodium | 126 | $4,219 |
| Hydroxychloroquine Sulfate | 100 | $3,228 |
| Pregabalin | 66 | $1,981 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 101 | $1,951 |
| Leflunomide | 35 | $1,751 |
| Gabapentin | 51 | $1,067 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 15 | $598 |
| Duloxetine Hcl | 25 | $569 |
| Tramadol Hcl | 100 | $505 |
| Prednisone | 90 | $479 |
| Tizanidine Hcl | 16 | $439 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenEnbrel, Otezla | $3,604 | $136,07223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Harrisburg
- Ryan HornungHarrisburg$18K
- Barbara LittleHarrisburg$12K
- Jodi JohnsonHarrisburg$11K
- Gina KoonsHarrisburg$10K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.